medigraphic.com
ISSN 0188-9796 (Print)

2013, Number 1

<< Back Next >>

Rev Endocrinol Nutr 2013; 21 (1)

Pattern of food intake and physical activity in patients with liver disease in western Mexico

Ramos-López O, Román S, Ojeda-Granados C, Sepúlveda-Villegas M, Martínez-López E, Torres-Valadez R, Trujillo-Trujillo E, Panduro A

Language: Spanish
References: 37
Page: 7-15
PDF size: 208.26 Kb.


ABSTRACT

Background: Malnutrition and sedentary lifestyle are environmental health components that influence the onset and progression of the chronic diseases. The analysis of such factors in patients with liver disease is important to establish prevention and therapeutic strategies. Objective: To characterize the pattern of food intake and physical activity in patients with liver disease. Methods: In a descriptive, cross-sectional study, 424 patients from western Mexico were studied: 12.7% had normal weight (BMI ‹ 25 kg/m2), 32.5% were overweight (BMI › 25 kg/m2), 32.5% were hepatitis C-infected patients and 22.22% were excessive alcohol intake (› 40 and › 20 g ethanol in men and women, respectively). Anthropometric, biochemical and dietary measures were obtained. Results: The normal weight group significantly consumed more fat and less fiber. The overweight and obese group omitted more meals, lacked a regular feeding schedule and was the most sedentary. The hepatitis C group had better eating habits, but was sedentary. The alcohol group consumed significantly more calories, cholesterol and sodium. Conclusion: In all study groups, a liver pathogenic diet due to high lipid content and nutrient deficiencies with antioxidant, anti-inflammatory and anti-fibrotic function was detected. The differences in the dietary patterns and physical activity between each liver disease group suggest that specific nutritional treatment strategies should be established in the Mexican population.


REFERENCES

  1. Sistema Nacional de Información en Salud. Principales causas de mortalidad general 2008. Disponible en: http://sinais.salud.gob.mx/mortalidad/

  2. Panduro A, Maldonado-Gonzalez M, Fierro NA, Roman S. Distribution of HBV genotypes F and H in Mexico and Central America. Antivir Ther. 2013; 18: 475-484.

  3. Zeyda M, Stulnig TM. Obesity, inflammation, and insulin resistance--a mini-review. Gerontology. 2009; 55: 379-386.

  4. Hull MW, Rollet K, Moodie EE, Walmsley S, Cox J, Potter M. Canadian Co-infection Cohort Study Investigators: Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients. AIDS. 2012; 26: 1789-1794.

  5. Macaluso FS, Maida M, Minissale MG, Li Vigni T, Attardo S, Orlando E Pettas S. Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int. 2013; 2013: 564645.

  6. Douglas MW, George J. Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol. 2009; 15: 4356-64.

  7. Rtveladze K, Marsh T, Barquera S, Sanchez Romero LM, Levy D, Melendez G et al. Obesity prevalence in Mexico: impact on health and economic burden. Public Health Nutr. 2013; 1: 1-7.

  8. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol. 2008; 22: 811-816.

  9. Ferolla SM, Ferrari TC, Lima ML, Reis TO, Tavares-Jr WC, Couto OF. Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. Clinics (Sao Paulo). 2013; 68: 11-17.

  10. Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol. 2010; 16: 2579-2588.

  11. Sullivan S. Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2010; 26: 160-164.

  12. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007; 47: 711-717.

  13. Mouzaki M, Allard JP. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol. 2012; 46: 457-467.

  14. Arroyo P. La alimentación en la evolución del hombre: su relación con el riesgo de enfermedades crónicas degenerativas. Bol Med Hosp Infant Mex. 2008; 65: 431-440.

  15. Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther. 2012; 36: 772-781.

  16. Rector RS, Thyfault JP. Does physical inactivity cause nonalcoholic fatty liver disease? J Appl Physiol. 2011; 111: 1828-1835.

  17. Subsecretaría de Prevención y Protección de la Salud. Centro Nacional de Vigilancia Epidemiológica. Programa de Salud del Adulto y el Anciano. Manual de Procedimientos. Toma de Medidas Clínicas y Antropométricas en el Adulto y Adulto Mayor 2002. Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/DOCSAL7518.pdf

  18. Norma Oficial Mexicana NOM-037-SSA2-2002, Para la prevención, tratamiento y control de las dislipidemias. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/037ssa202.html

  19. American Diabetes Association: Standards of medical care in diabetes 2013. Diabetes Care. 2013; 36: S11-66.

  20. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Energía, proteína, vitaminas y minerales para la población Mexicana. En: Tablas de composición de alimentos mexicanos 2000. Disponible en: http://www.facmed.unam.mx/deptos/salud/censenanza/spi/unidad2/micronut.pdf

  21. Pérez LAB, Marvan LL. Manual de dietas normales y terapéuticas: los alimentos en la salud y en la enfermedad 5 ed. México, DF; La Prensa Médica Mexicana, 2005.

  22. Zivkovic AM, German JB, Sanyal AJ: Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liverdisease. Am J Clin Nutr. 2007; 86: 285-300.

  23. Wang D, O’Horo J. Antifibrotic effects of ω-3 fatty acids in the heart: one possible treatment for diastolic heart failure. Trends Cardiovasc Med. 2011; 21: 90-95.

  24. Houston MC. The role of celular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis. 2010; 4: 165-183.

  25. Encuesta Nacional de Salud y Nutrición. Resultados Nacionales 2012. Disponible en: http://ensanut.insp.mx/informes/ENSANUT2012ResultadosNacionales.pdf

  26. Medina C, Barquera S, Janssen I. Resultados de actividad física y sedentarismo en personas de 10 a 69 años. Encuesta Nacional de Salud y Nutrición. Evidencia para la política pública en Salud 2012. Disponible en: http://ensanut.insp.mx/doctos/analiticos/ActividadFisica.pdf

  27. Barquera S, Tolentino L. Geografía de las enfermedades asociadas con la nutrición en México: una perspectiva de transición epidemiológica. Papeles de Población. 2005; 043: 133-148.

  28. D’Addesa D, D’Addezio L, Martone D, Censi L, Scanu A, Cairella G. Dietary intake and physical activity of normal weight and overweight adolescents. Int J Pediatr. 2010; 2010: 785649.

  29. Kim CH, Kallman JB, Bai C, Pawloski L, Gewa C, Arsalla A. Nutritional assessments of patients with non-alcoholic fatty liver disease. Obes Surg. 2010; 20: 154-160.

  30. Baraboĭ VA, Shestakova EN. Selenium: the biological role and antioxidant activity. Ukr Biokhim Zh. 2004; 76: 23-32.

  31. Mesas AE, Guallar-Castillón P, León-Muñoz LM, Graciani A, López-García E, Gutiérrez-Fisac JL. Obesity-related eating behaviors are associated with low physical activity and poor diet quality in Spain. J Nutr. 2012; 142: 1321-1328.

  32. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004; 89: 2583-2589.

  33. Felmlee DJ, Hafirassou ML, Lefevre M, Baumert TF, Schuster C. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Viruses 2013; 5: 1292-1324.

  34. Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P: Hepatitis C and diabetes: the inevitable coincidence? Expert Rev Anti Infect Ther. 2009; 7: 293-308.

  35. Yeomans MR. Alcohol, appetite and energy balance: is alcohol intake a risk factor for obesity? Physiol Behav. 2010; 100: 82-89.

  36. Yeomans MR, Caton S, Hetherington MM: Alcohol and food intake. Curr Opin Clin Nutr Metab Care. 2003; 6: 639-644.

  37. Gao B, Bataller R: Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141: 1572-1585.




2020     |     www.medigraphic.com